How CRISPR works, explained in two minutes

HereatSTAT,wespendalotoftimetryingtoimagine—andrender—theinvisible.We’vegoneinsideofadevelopingembry MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending




explore

author：focus    Page View：74653
Ed Silverman on the Breakthrough Summit stage in 2023.
STAT's Ed Silverman on stage at the STAT Breakthrough Summit in 2023. Sarah Gonzalez for STAT

In 2023, STAT launched a brand-new home for our subscribers to connect with each other and with their favorite STAT journalists. On STAT+ Connect, you can find job postings; comment on STAT articles (since we have closed comments on article pages); discuss industry events with other people who work in biotech, pharma, public health advocacy, PR, and more; read insights and exclusive material posted by STAT reporters and editors; and watch events, including live interviews and text-based Ask Me Anything chats.

Last week, Ed Silverman, AKA Pharmalot, hosted an AMA titled “Stump Pharmalot.” During the AMA, Ed discussed gene therapy, his proudest career moments, what he took in high school instead of chemistry, coffee (or, as he calls it, “cups of stimulation”), and more.

advertisement

Below, you can find a lightly edited transcript of the conversation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： Carvykti CAR
Next article： Medicare details structure of new drug price negotiation program